Hematologic Safety of Breast Cancer Chemotherapies in Patients with Hepatitis B or C Virus Infection

Publisher： Karger

E-ISSN： 1423-0232|82|4|228-233

ISSN： 0030-2414

Source： Oncology, Vol.82, Iss.4, 2012-04, pp. : 228-233

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer

By  

CANCER, Vol. 124, Iss. 5, 2018-03 ,pp. : 960-965

John Wiley & Sons Inc

Access to resources Recommend Favorite

Real‐world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 3, 2018-03 ,pp. : 710-717

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phylogenetic Analysis of Hepatitis GB Virus Type C/Hepatitis G Virus in Spanish Patients with Chronic Hepatitis B or C Virus Infection

By  

Intervirology, Vol. 41, Iss. 6, 1999-05 ,pp. : 233-237

Karger

Access to resources Recommend Favorite

Lack of Epidemiological Evidence for a Role of Resolved Hepatitis B Virus Infection in Hepatocarcinogenesis in Patients Infected with Hepatitis C Virus in Japan

By  

Intervirology, Vol. 46, Iss. 3, 2003-07 ,pp. : 171-176

Karger

Access to resources Recommend Favorite

Impact of hepatitis E virus seropositivity on chronic liver disease in cancer patients with hepatitis C virus infection

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 11, 2015-11 ,pp. : 1146-1151

John Wiley & Sons Inc

Access to resources Recommend Favorite